Pregled bibliografske jedinice broj: 290346
Periacinar Retraction Clefting in Proliferative Prostatic Atrophy and Prostatic Adenocarcinoma
Periacinar Retraction Clefting in Proliferative Prostatic Atrophy and Prostatic Adenocarcinoma // Journal of clinical pathology, 60 (2007), 10; 1098-1101 doi:10.1136/jcp.2006.044784 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 290346 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Periacinar Retraction Clefting in Proliferative Prostatic Atrophy and Prostatic Adenocarcinoma
Autori
Ulamec, Monika ; Tomas, Davor ; Ensinger, Christian ; Čupić, Hrvoje ; Belicza, Mladen ; Mikuz, Gregor ; Krušlin, Božo
Izvornik
Journal of clinical pathology (0021-9746) 60
(2007), 10;
1098-1101
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
prostatic adenocarcinoma; prostatic atrophy; retraction clefting
Sažetak
The purpose of this study was to evaluate the presence and extent of periacinar retraction clefting in proliferative prostatic atrophy and carcinoma in radical prostatectomy specimens. Atrophic foci and neoplastic glands were analyzed in specimens from 50 patients who underwent radical prostatectomy. Analyzed atrophic glands were classified in two main groups, proliferative atrophy (PA) and proliferative inflammatory atrophy (PIA), and each group was subclassified into simple atrophy (SA) and postatrophic hyperplasia (PAH). According to the presence and extent of periacinar retraction clefting atrophic and neoplastic glands were classified as: group 1 - glands without clefts or with clefts affecting up to 50% of gland circumference, group 2 - glands with clefts that affected more than 50% of the circumference in less than 50% of examined glands and group 3 - glands with clefts that affected more than 50% of the circumference in more than 50% of examined glands. Forty-four (88.0%) atrophic foci were without periacinar clefts or clefts were present in less than half of gland circumference (Group 1). In 6 (12.0%) atrophic foci clefts affected more than 50% of gland circumference (Groups 2 and 3). Forty-five (90.0%) carcinomas were with clefts which affected more than 50% of gland circumference (Groups 2 and 3), and only in five carcinomas clefts were not found or affected less than 50% of gland circumference (Group 1). Our results indicate that periacinar retraction clefting represents a reliable criterion in differential diagnosis between proliferative atrophy and carcinoma.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-1081870-1884 - Razvojna neuropatologija genetskih malformacija moždane kore čovjeka (Krušlin, Božo, MZOS ) ( CroRIS)
134-0000000-3381 - Promjene bubrežne arterije u bolesnika s karcinomom bubrega (Čupić, Hrvoje, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE